Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven

Condition:   Acute Myeloid Leukemia Interventions:   Other: Pharmacokinetic sampling;   Other: Vital status determination;   Other: Toxicity assessments;   Drug: Venetoclax and azacitidine combination Sponsor:   Centre Hospitalier Universitaire de Nice Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials